MALAT1 and breast carcinoma: A large amount of research has reported that aberrantly expressed MALAT1 was involved in a variety of cancers, such as breast cancer metastasis (Kim et al., 2018), colon cancer (Wu et al., 2018), and non-small cell lung cancer (Li et al., 2018).